ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years

June 17, 2011

ASCO Urges Sustained Support For Cancer Research, Clinical Trials

March 27, 2009

NCI To Evaluate Chernobyl Effects On Soviet Health

November 23, 1990

President Clinton Seeks 8% Increase For NCI; Most Institute Take Cuts In $10 Bll. NIH Budget

April 16, 1993

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

Health Association Oppose U.S. Trade Policy On Tobacco Exports; Recommend Restrictions

August 25, 1989